FLUPHENAZINE INJ
Clinical Criteria Summary
Transitioning Veteran Status
- Veteran is transitioning care from the Department of Defense to VHA
- VA prescriber has determined that continuing the medication is safe and clinically appropriate (remainder of criteria not applicable if met)
Exclusion Criteria
- Patient has never taken the long-acting injectable antipsychotic ordered in any formulation (e.g., oral)
- Patient has a hypersensitivity to the antipsychotic ordered
Required Inclusion Criteria (All Must Be Met)
- Diagnosis of schizophrenia or schizoaffective disorder, or bipolar disorder
- Prescriber is a VA Mental Health Provider
- Patient has taken and tolerated the antipsychotic ordered prior to receiving it as a LAI for an adequate length of time
- Patient will be transitioned from oral/short-acting injection medication to the long-acting injectable per guidelines/manufacturer recommendations
Alternative Inclusion Criteria (One Must Be Met)
- Patient has relapsed or been hospitalized for the intended indication or complications of the intended indication because of nonadherence when treated with oral antipsychotics
- Patient’s care environment is such that a LAI is a more reliable route of administration (e.g., homeless, lack of medication supervision, or medication cannot be stored safely)